These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 89971

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. VIP enhances TRH-stimulated prolactin secretion of pituitary tumours. Studies with 31P NMR.
    Prysor-Jones RA, Silverlight JJ, Jenkins JS, Stevens AN, Rodrigues JL, Griffiths JR.
    FEBS Lett; 1984 Nov 05; 177(1):71-5. PubMed ID: 6437866
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Vasoactive intestinal peptide increases prolactin messenger ribonucleic acid content in GH3 cells.
    Carrillo AJ, Pool TB, Sharp ZD.
    Endocrinology; 1985 Jan 05; 116(1):202-6. PubMed ID: 2856872
    [Abstract] [Full Text] [Related]

  • 26. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
    Le Péchon-Vallée C, Magalon K, Rasolonjanahary R, Enjalbert A, Gérard C.
    Neuroendocrinology; 2000 Jul 05; 72(1):46-56. PubMed ID: 10940738
    [Abstract] [Full Text] [Related]

  • 27. In GH3 pituitary cells, acetylcholine and vasoactive intestinal peptide antagonistically modulate adenylate cyclase, cyclic AMP content, and prolactin secretion.
    Onali P, Eva C, Olianas MC, Schwartz JP, Costa E.
    Mol Pharmacol; 1983 Sep 05; 24(2):189-94. PubMed ID: 6310360
    [Abstract] [Full Text] [Related]

  • 28. Vasoactive intestinal peptide increases intracellular free calcium in rat and human pituitary tumour cells in vitro.
    Prysor-Jones RA, Silverlight JJ, Jenkins JS.
    J Endocrinol; 1987 Jul 05; 114(1):119-23. PubMed ID: 3116135
    [Abstract] [Full Text] [Related]

  • 29. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
    Aizawa T, Hinkle PM.
    Endocrinology; 1985 Mar 05; 116(3):909-19. PubMed ID: 3918848
    [Abstract] [Full Text] [Related]

  • 30. Single and dual hormone secretors in GH3 cultures respond differently to hypothalamic factors.
    Mogg RJ, Boockfor FR.
    Mol Cell Endocrinol; 1992 Sep 05; 87(1-3):1-8. PubMed ID: 1446781
    [Abstract] [Full Text] [Related]

  • 31. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
    Dorflinger LJ, Schonbrunn A.
    Endocrinology; 1983 Nov 05; 113(5):1551-8. PubMed ID: 6138245
    [Abstract] [Full Text] [Related]

  • 32. Effect of vasoactive intestinal peptide (VIP) on the release of adenohypophyseal hormones from purified cells obtained by unit gravity sedimentation. Inhibition by dexamethasone of vip-induced prolactin release.
    Rotsztejn WH, Benoist L, Besson J, Beraud G, Bluet-Pajot MT, Kordon C, Rosselin G, Duval J.
    Neuroendocrinology; 1980 Oct 05; 31(4):282-6. PubMed ID: 7422069
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain.
    Quik M, Iversen LL, Bloom SR.
    Biochem Pharmacol; 1978 Oct 05; 27(18):2209-13. PubMed ID: 83146
    [No Abstract] [Full Text] [Related]

  • 37. The effects of dopaminergic antagonism by sulpiride on TRH and VIP-induced prolactin release in nonsuckled lactating rats.
    Haisenleder DJ, Moy JA, Lawson DM.
    Life Sci; 1990 Oct 05; 46(25):1867-72. PubMed ID: 2163481
    [Abstract] [Full Text] [Related]

  • 38. Prolactin release by vasoactive intestinal polypeptide in rats.
    Kato Y, Iwasaki Y, Iwasaki J, Abe H, Yanaihara N, Imura H.
    Endocrinology; 1978 Aug 05; 103(2):554-8. PubMed ID: 744101
    [Abstract] [Full Text] [Related]

  • 39. Prolactin release from MtTW15 and 7315a pituitary tumors is refractory to TRH and VIP stimulation.
    Judd AM, Canonico PL, MacLeod RM.
    Mol Cell Endocrinol; 1984 Jul 05; 36(3):221-8. PubMed ID: 6088325
    [Abstract] [Full Text] [Related]

  • 40. Energy metabolism in rat pituitary tumors during stimulation of prolactin by vasoactive intestinal polypeptide and thyrotropin-releasing hormone: a study with nuclear magnetic resonance spectroscopy.
    Prysor-Jones RA, Silverlight JJ, Jenkins JS, Maxwell R, Griffiths JR.
    Endocrinology; 1986 Dec 05; 119(6):2574-9. PubMed ID: 3096693
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.